glp 1 startups GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Size

I am here with NPR pharmaceuticals correspondent Sydney Lupkin today to talk about something that has really changed the game when it comes to weight loss, which is injections

but is available in the European Union, Japan, Brazil, and India and is available under the name Lyxumia in more than 60 countries

Its also expensive

Drug interactions and side effects of Exenatide Regulatory Approvals/Commerical Initially developed by Amylin Pharmaceuticals, Exenatide was approved by the US FDA in April 2005 with the commercial name Byetta

Clinical data supports this concern

These findings suggest that early discontinuation may diminish the cardiovascular benefits of GLP-1 RAs, underscoring the importance of treatment persistence when evaluating real-world outcomes